Relacorilant Treatment Improves Glycemic Control Among Individuals With Cushing Syndrome (Endogenous Hypercortisolism) and Hyperglycemia on Glucagon-Like Peptide-1 Receptor Agonists: Insights From a Phase 3 Study
Presented: American Association of Clinical Endocrinology, 24 April 2026, Las Vegas, NV
Presenter: Julie M. Silverstein, M.D.
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.